Fig. 5From: Mesenchymal stem cell-derived exosomes enriched with miR-218 reduce the epithelial–mesenchymal transition and angiogenesis in triple-negative breast cancer cellsmiR-218 containing exosomes inhibit migration and invasion of MDA-MB-231 cells in vitro. a Representative photomicrographs showing the scratch assay of MDA‐MB‐231 cells treated with miR‐218 containing exosomes. b Bar graphs showing the significant decrease in motility of the cells treated with miR‐218 containing exosomes compared with control. c Representative photomicrographs showing the transwell migration assay of MDA‐MB‐231 cells treated with miR‐218 loaded exosomes. d Bar graphs showing the significant decrease in migration of the cells treated with miR‐218 containing exosomes. e Representative photomicrographs showing the transwell invasion assay of MDA‐MB‐231 cells treated with miR‐218 containing exosomes. f Bar graphs showing the significant decrease in invasion of the cells treated with miR‐218 loaded exosomes. Data are shown as mean ± SD from 3 independent experiments. (*p < 0.05 and **p < 0.001)Back to article page